Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share Price

Price 30.00p on 27-05-2025 at 16:30:01
Change 3.00p 10.71%
Buy 31.00p
Sell 29.00p
Buy / Sell AVCT Shares
Last Trade: Buy 150,000.00 at 31.00p
Day's Volume: 3,044,731
Last Close: 31.00p
Open: 26.00p
ISIN: GB00BYYW9G87
Day's Range 31.00p - 31.00p
52wk Range: 26.00p - 82.50p
Market Capitalisation: £120m
VWAP: 28.46417p
Shares in Issue: 387m

Avacta Group (AVCT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 150,000 31.00p Suspected BUY Trade
16:40:29 - 27-May-25
Sell* 100,000 29.00p Ordinary
16:38:52 - 27-May-25
Sell* 100,000 28.00p Negotiated Trade
16:38:48 - 27-May-25
Sell* 250,000 27.00p Negotiated Trade
16:38:46 - 27-May-25
Buy* 651 30.70p Ordinary
16:29:53 - 27-May-25
Sell* 11,644 30.111p Ordinary
16:29:40 - 27-May-25
Sell* 19,662 30.489p Ordinary
16:27:12 - 27-May-25
Buy* 25,000 31.00p Ordinary
16:24:40 - 27-May-25
Buy* 10,000 30.60p Ordinary
16:20:59 - 27-May-25
Sell* 33,243 30.10p Ordinary
16:20:53 - 27-May-25
See more Avacta Group trades

Avacta Group (AVCT) Share Price History

Time period:
to
Date Open High Low Close Volume
26th May 2025 (Mon) 28.00 28.00 28.00 28.00 0
23rd May 2025 (Fri) 28.25 28.50 27.25 27.50 1,981,230
22nd May 2025 (Thu) 29.75 28.65 27.50 28.25 2,230,269
21st May 2025 (Wed) 30.00 30.00 29.00 29.75 1,327,022
20th May 2025 (Tue) 32.00 32.00 29.50 30.00 3,585,062
19th May 2025 (Mon) 33.00 33.00 32.00 32.00 702,896
16th May 2025 (Fri) 34.00 34.00 31.50 33.00 1,819,146
15th May 2025 (Thu) 34.50 35.00 34.00 34.00 599,796
14th May 2025 (Wed) 34.00 34.50 34.00 34.50 700,286
13th May 2025 (Tue) 33.00 35.00 33.00 34.00 1,005,616
12th May 2025 (Mon) 33.00 34.00 33.00 33.00 749,213
9th May 2025 (Fri) 33.50 34.50 32.75 32.75 1,439,646
8th May 2025 (Thu) 33.50 35.00 32.00 33.50 1,095,668
7th May 2025 (Wed) 34.00 34.00 33.00 33.50 773,678
6th May 2025 (Tue) 34.25 35.00 34.00 34.00 754,740
5th May 2025 (Mon) 34.00 34.00 34.00 34.00 0
2nd May 2025 (Fri) 33.00 35.00 33.00 34.50 634,370
1st May 2025 (Thu) 33.75 33.75 33.00 33.00 389,559
30th Apr 2025 (Wed) 34.00 34.50 33.00 33.25 842,873
29th Apr 2025 (Tue) 32.50 35.00 32.50 34.00 2,016,923
28th Apr 2025 (Mon) 32.50 34.00 31.50 32.50 4,160,490
See more Avacta Group price history

Avacta Group (AVCT) Regulatory News

Date Source Headline
15th May 2025 7:00 am RNS Notice of Results
12th May 2025 12:00 pm RNS-R Investor Webinar
8th May 2025 7:30 am RNS Block Listing Application to AIM
29th Apr 2025 7:00 am RNS Board change
28th Apr 2025 5:52 pm RNS Block Listing Six Monthly Return
28th Apr 2025 7:01 am RNS Avacta presents preclinical data at AACR
28th Apr 2025 7:00 am RNS Avacta presents data from lead candidate at AACR
23rd Apr 2025 7:00 am RNS Issue of Equity and Total Voting Rights
31st Mar 2025 7:00 am RNS Avacta Quarterly Update
26th Mar 2025 7:00 am RNS Avacta Announces Presentations at AACR
See more Avacta Group regulatory news

Avacta Group (AVCT) Share News

Avacta sells Launch Diagnostics; reports "promising" efficacy data

7th Mar 2025 12:42

(Alliance News) - Avacta Group PLC on Friday said it has agreed to sell its UK-based and largest diagnostics unit, Launch Diagnostics Holdings Ltd, and reported "promising" early efficacy data in the treatment of salivary gland cancers. Read More

AIM WINNERS & LOSERS: Avacta makes progress on AVA6000 testing

7th Mar 2025 10:28

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

EXECUTIVE CHANGES: Various Eateries hires Young's executive as CEO

13th Jan 2025 14:59

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

10th Dec 2024 10:01

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

Avacta partners with Tempus to enable AI-driven drug development

21st Oct 2024 14:31

(Alliance News) - Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus AI Inc, to optimise its clinical development process and enable "the highest probability of success". Read More

See more Avacta Group news
FTSE 100 Latest
Value8,778.05
Change60.08

Login to your account

Forgot Password?

Not Registered